Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Nature Biotechnology
|
April 8, 2006
The paths around stem cell intellectual property
Kenneth S Taymor, Christopher Thomas Scott, Henry T Greely
Cell Stem Cell
|
February 10, 2009
Distribution of human embryonic stem cell lines: who, when, and where
Jennifer B McCormick, Jason Owen-Smith, Christopher Thomas Scott
Nature Biotechnology
|
August 12, 2009
And then there were two: use of hESC lines
Christopher Thomas Scott, Jennifer B McCormick, Jason Owen-Smith
Journal of Law and the Biosciences
|
November 24, 2022
Prescribing unproven cancer drugs: physician perspectives on expanded access and right to try
Haley Manley, Bryan A Sisk, Zubin Master, et al.
Nature Biotechnology
|
April 10, 2014
The time is ripe for an ethics of entrepreneurship
Christopher Thomas Scott, Emily L Borgelt, Sandra Soo-Jin Lee
Nature Methods
|
October 30, 2010
Federal policy and the use of pluripotent stem cells
Christopher Thomas Scott, Jennifer B McCormick, Mindy C Derouen, et al.
Cell
|
June 14, 2011
Democracy derived? New trajectories in pluripotent stem cell research
Christopher Thomas Scott, Jennifer B McCormick, Mindy C DeRouen, et al.
Stem Cell Reviews and Reports
|
June 21, 2012
The race is on: human embryonic stem cell research goes global
Mindy C DeRouen, Jennifer B McCormick, Jason Owen-Smith, et al.
Cell Stem Cell
|
April 9, 2011
Donation of embryos for human development and stem cell research
Tasha Kalista, H Austinn Freeman, Barry Behr, et al.
Science & Public Policy
|
July 22, 2024
Governing with public engagement: an anticipatory approach to human genome editing
Dorit Barlevy, Eric Juengst, Jeffrey Kahn, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Nature Biotechnology
|
April 8, 2006
The paths around stem cell intellectual property
Kenneth S Taymor, Christopher Thomas Scott, Henry T Greely
Cell Stem Cell
|
February 10, 2009
Distribution of human embryonic stem cell lines: who, when, and where
Jennifer B McCormick, Jason Owen-Smith, Christopher Thomas Scott
Nature Biotechnology
|
August 12, 2009
And then there were two: use of hESC lines
Christopher Thomas Scott, Jennifer B McCormick, Jason Owen-Smith
Journal of Law and the Biosciences
|
November 24, 2022
Prescribing unproven cancer drugs: physician perspectives on expanded access and right to try
Haley Manley, Bryan A Sisk, Zubin Master, et al.
Nature Biotechnology
|
April 10, 2014
The time is ripe for an ethics of entrepreneurship
Christopher Thomas Scott, Emily L Borgelt, Sandra Soo-Jin Lee
Nature Methods
|
October 30, 2010
Federal policy and the use of pluripotent stem cells
Christopher Thomas Scott, Jennifer B McCormick, Mindy C Derouen, et al.
Cell
|
June 14, 2011
Democracy derived? New trajectories in pluripotent stem cell research
Christopher Thomas Scott, Jennifer B McCormick, Mindy C DeRouen, et al.
Stem Cell Reviews and Reports
|
June 21, 2012
The race is on: human embryonic stem cell research goes global
Mindy C DeRouen, Jennifer B McCormick, Jason Owen-Smith, et al.
Cell Stem Cell
|
April 9, 2011
Donation of embryos for human development and stem cell research
Tasha Kalista, H Austinn Freeman, Barry Behr, et al.
Science & Public Policy
|
July 22, 2024
Governing with public engagement: an anticipatory approach to human genome editing
Dorit Barlevy, Eric Juengst, Jeffrey Kahn, et al.
Page
of 6